MY ACCOUNT | NEWSLETTER |

Clinical Signs and Diagnosis of the Canine Primary Glaucomas


A clinician’s working definition of glaucoma determines which clinical signs and diagnostic values are considered important and pivotal in directing therapy. Unfortunately, there is no clear consensus on the definition of glaucoma or its various forms in human or veterinary medicine.1,2 For more than 100 years, glaucoma has been thought of as a “disease of elevated intraocular pressure (IOP)” and this parameter has been emphasized as the defining clinical sign, diagnostic variable, and therapeutic guide. This remains true for the vast majority of patients with glaucoma in veterinary medicine. Recent advances in both human and veterinary medicine, however, have demonstrated that damage to the optic nerve or associated tissues, such as the retinal nerve fiber layer (RNFL) can occur before IOP increases are documented or even after IOP has returned to normal values. This indicates that IOP alone is not the sole characteristic that defines the presence or absence of glaucoma and this fact has caused vision scientists to focus on the anatomic and molecular mechanisms that lead to the characteristic optic disc and visual field changes resulting in glaucomatous vision loss. The evolution of the definition of glaucoma to essentially a specific type of optic neuropathy has led to the proliferation of other diagnostic techniques that evaluate the posterior segment in more detail and tend to de-emphasize the role that IOP plays in this disorder.


For the purpose of this article, “primary glaucoma” is defined as a group of disorders that are typically bilateral, have a strong breed predisposition, are associated with increasing age, are documented or believed to have a genetic basis,3–5 result in characteristic changes to the optic nerve, and have no readily identifiable secondary ocular or systemic cause on routine ophthalmic examination. IOP is an important risk factor but not the sole risk factor for glaucomatous damage. The gonioscopic appearance of the iridocorneal angle (ICA) further categorizes primary glaucoma into “open” and “closed” forms. The term “primary angle closure glaucoma” (PACG) is used to reflect that the gonioscopic appearance of the ICA changes over time and eventually this structure appears closed.6,7 In clinical practice, PACG is many times more frequent than primary open angle glaucoma (POAG) in dogs and as such will be emphasized here.


Authors: Paul E Miller, Ellison Bentley

Source: https://pmc.ncbi.nlm.nih.gov/

Like1
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top